Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antifungal combination therapy: clinical potential.

John W Baddley1, Peter G Pappas

  • 1Department of Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, and Birmingham Veteran's Administration Medical Center, Birmingham, Alabama 35294-0006, USA.

Drugs
|July 22, 2005
PubMed
Summary

Combination antifungal therapy shows promise for invasive fungal infections. Clinical data confirm amphotericin B plus flucytosine for cryptococcal meningitis and suggest benefits for candidiasis and aspergillosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rezafungin Versus Caspofungin in Candidaemia and Invasive Candidiasis: A Post Hoc Pooled Analysis of Phase 2 and Phase 3 Trials.

Mycoses·2026
Same author

Demographics and Geographic Accessibility of Invasive Fungal Infection Clinical Trial Sites.

JAMA network open·2026
Same author

Frequency and Duration of Diagnostic Delays Associated with Coccidioidomycosis and Risk Factors for Missed Diagnoses, United States.

Emerging infectious diseases·2026
Same author

International Survey on Screening and Management of Strongyloidiasis in Solid Organ Transplant Patients.

Transplant infectious disease : an official journal of the Transplantation Society·2026
Same author

Epidemiology and Clinical Features of Cryptococcosis Among Individuals Without HIV Infection: An Observational International Multicenter Study (MSG-11).

Open forum infectious diseases·2026
Same author

Invasive fungal infections after Bruton tyrosine kinase inhibitor treatment: a systematic review and meta-analysis.

Blood advances·2026

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Combination antifungal therapy has been researched for decades.
  • Recent advancements in antifungal agents have renewed interest in combination therapy.
  • Clinical studies on combination antifungal therapy were historically limited.

Purpose of the Study:

  • To review current clinical data on combination antifungal therapy for invasive fungal infections.
  • To provide insights into future clinical directions for combination antifungal strategies.
  • To offer a comprehensive overview of this complex therapeutic area.

Main Methods:

  • Focus on clinical data rather than a comprehensive experimental review.
  • Analysis of clinical trial outcomes for specific fungal infections.

Related Experiment Videos

  • Inclusion of data on newer antifungal agents like echinocandins and extended-spectrum triazoles.

    • Main Results:

    • Amphotericin B plus flucytosine is confirmed as the most active combination for cryptococcal meningitis.
    • A clinical trial in candidemia indicated a trend towards improved outcomes with amphotericin B plus fluconazole versus fluconazole alone.
    • Prospective clinical trials have not yet confirmed benefits suggested by experimental models for aspergillosis combinations.

    Conclusions:

    • Combination antifungal therapy remains a critical area of research for invasive fungal infections.
    • Specific combinations show efficacy in certain infections, such as amphotericin B plus flucytosine for cryptococcal meningitis.
    • Further clinical trials are needed to validate the efficacy of various combination therapies, particularly for invasive aspergillosis.